Ieq Capital LLC cut its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 28.5% during the 1st quarter, HoldingsChannel reports. The fund owned 8,190 shares of the pharmacy operator’s stock after selling 3,264 shares during the quarter. Ieq Capital LLC’s holdings in Walgreens Boots Alliance were worth $374,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Savant Capital LLC boosted its holdings in shares of Walgreens Boots Alliance by 87.2% during the 1st quarter. Savant Capital LLC now owns 30,824 shares of the pharmacy operator’s stock valued at $1,410,000 after buying an additional 14,359 shares in the last quarter. ING Groep NV raised its position in Walgreens Boots Alliance by 46.0% in the 4th quarter. ING Groep NV now owns 57,426 shares of the pharmacy operator’s stock worth $3,386,000 after buying an additional 18,085 shares during the last quarter. Great Lakes Advisors LLC raised its position in Walgreens Boots Alliance by 74.2% in the 4th quarter. Great Lakes Advisors LLC now owns 13,701 shares of the pharmacy operator’s stock worth $808,000 after buying an additional 5,835 shares during the last quarter. Hartford Investment Management Co. raised its position in Walgreens Boots Alliance by 3.4% in the 4th quarter. Hartford Investment Management Co. now owns 120,397 shares of the pharmacy operator’s stock worth $7,099,000 after buying an additional 4,007 shares during the last quarter. Finally, Assenagon Asset Management S.A. raised its position in Walgreens Boots Alliance by 27.3% in the 1st quarter. Assenagon Asset Management S.A. now owns 233,075 shares of the pharmacy operator’s stock worth $10,663,000 after buying an additional 49,936 shares during the last quarter. Hedge funds and other institutional investors own 59.79% of the company’s stock.

Shares of NASDAQ:WBA traded down $0.45 during trading on Friday, reaching $38.40. The stock had a trading volume of 17,309,296 shares, compared to its average volume of 7,309,966. The business has a fifty day moving average price of $42.94 and a 200-day moving average price of $51.89. The stock has a market cap of $35.55 billion, a PE ratio of 9.85, a PEG ratio of 1.92 and a beta of 0.55. The company has a debt-to-equity ratio of 1.34, a quick ratio of 0.32 and a current ratio of 0.66. Walgreens Boots Alliance Inc has a 1-year low of $36.65 and a 1-year high of $64.50.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, April 2nd. The pharmacy operator reported $1.52 EPS for the quarter, beating the Zacks’ consensus estimate of $1.46 by $0.06. The company had revenue of $35.82 billion for the quarter, compared to the consensus estimate of $35.24 billion. Walgreens Boots Alliance had a return on equity of 21.26% and a net margin of 2.52%. The company’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.64 earnings per share. Sell-side analysts expect that Walgreens Boots Alliance Inc will post 5.53 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Stockholders of record on Wednesday, May 20th will be given a dividend of $0.4575 per share. The ex-dividend date is Tuesday, May 19th. This represents a $1.83 annualized dividend and a dividend yield of 4.77%. Walgreens Boots Alliance’s dividend payout ratio is currently 30.55%.

A number of brokerages have weighed in on WBA. SunTrust Banks decreased their target price on Walgreens Boots Alliance from $58.00 to $42.00 and set a “hold” rating for the company in a research report on Friday, April 3rd. Credit Suisse Group reduced their price target on shares of Walgreens Boots Alliance from $60.00 to $50.00 and set a “neutral” rating for the company in a research report on Friday, April 3rd. ValuEngine lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday, March 3rd. UBS Group raised shares of Walgreens Boots Alliance from a “sell” rating to a “neutral” rating and reduced their price target for the company from $49.00 to $44.00 in a research report on Monday, April 6th. Finally, Deutsche Bank raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating and reduced their price target for the company from $51.00 to $43.00 in a research report on Friday, April 3rd. Four research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company. The stock presently has an average rating of “Hold” and an average price target of $51.64.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

See Also: Technical Analysis

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.